BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12386304)

  • 1. Gene therapy. What to do when clear success comes with an unclear risk?
    Marshall E
    Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy. RAC's advice: proceed with caution.
    Kaiser J
    Science; 2002 Dec; 298(5601):2113-5. PubMed ID: 12481114
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy. RAC hears a plea for resuming trials, despite cancer risk.
    Kaiser J
    Science; 2003 Feb; 299(5609):991. PubMed ID: 12586909
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy. Panel urges limits on X-SCID trials.
    Kaiser J
    Science; 2005 Mar; 307(5715):1544-5. PubMed ID: 15761128
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
    Kaiser J
    Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 7. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy insertional mutagenesis insights.
    Davé UP; Jenkins NA; Copeland NG
    Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer risk prompts US to curb gene therapy.
    Check E
    Nature; 2003 Mar; 422(6927):7. PubMed ID: 12621402
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
    Couzin J; Kaiser J
    Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
    [No Abstract]   [Full Text] [Related]  

  • 11. Good news for gene therapy.
    Berns A
    N Engl J Med; 2004 Apr; 350(16):1679-80. PubMed ID: 15084702
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer fears cast doubts on future of gene therapy.
    Check E
    Nature; 2003 Feb; 421(6924):678. PubMed ID: 12610583
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulators split on gene therapy as patient shows signs of cancer.
    Check E
    Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936
    [No Abstract]   [Full Text] [Related]  

  • 14. Bubble babies and bathwater.
    Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical research. Gene therapy a suspect in leukemia-like disease.
    Marshall E
    Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
    [No Abstract]   [Full Text] [Related]  

  • 16. Success and setback: another adverse event.
    Verma IM
    Mol Ther; 2002 Nov; 6(5):565-6. PubMed ID: 12409253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodology of gene therapy: adverse events and further technological developments].
    Hamada H
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():601-6. PubMed ID: 20979308
    [No Abstract]   [Full Text] [Related]  

  • 18. Harmful potential of viral vectors fuels doubts over gene therapy.
    Check E
    Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy resumes.
    Novak K
    Nat Rev Cancer; 2002 Nov; 2(11):813. PubMed ID: 12442759
    [No Abstract]   [Full Text] [Related]  

  • 20. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.